Zhejiang Zhebei Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Zhejiang Zhebei Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 7 active records with this name as holder; 7 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
17 acceptance records as first applicant, grouped into 14 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2026/08/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601871 | Generic | 2026/08/03 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
Ethyl Iosapentate Capsules 1 records · Latest accepted 2026/07/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601563 | Generic | 2026/07/02 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Eldecalcitol Soft Capsules 2 records · Latest accepted 2025/12/05
Generic · 2
Valacyclovir Hydrochloride Tablets 1 records · Latest accepted 2025/08/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502932 | Generic | 2025/08/12 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
瑞巴派特片 · No verified English name 1 records · Latest accepted 2025/05/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501934 | Generic | 2025/05/30 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Colchicine Tablets 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500508 | Generic | 2025/01/27 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Amisulpride Oral Solution 1 records · Latest accepted 2024/12/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404541 | Generic | 2024/12/26 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Aripiprazole Oral Solution 1 records · Latest accepted 2024/12/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404139 | Generic | 2024/12/03 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Betamethasone Sodium Phosphate Injection 2 records · Latest accepted 2024/07/30
Supplement · 1Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401135 | Supplement | 2024/07/30 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | CDE ↗ |
| CYHS2400710 | Generic | 2024/02/28 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | CDE ↗ |
骨化三醇胶丸 · No verified English name 1 records · Latest accepted 2024/05/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401354 | Generic | 2024/05/08 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Minoxidil Liniment 2 records · Latest accepted 2024/04/24
Generic · 2
青霉素皮试剂 · No verified English name 1 records · Latest accepted 2024/02/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400237 | Supplement | 2024/02/08 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. | CDE ↗ |
Pregabalin Oral Solution 1 records · Latest accepted 2023/10/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302826 | Generic | 2023/10/21 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Mercaptopurine Tablets 1 records · Latest accepted 2021/04/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150547 | Supplement | 2021/04/23 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Rosuvastatin Calcium and Ezetimibe Tablets (I) | CYHS2601871 | Generic | 2026/08/03 | Zhejiang Zhebei Pharmaceutical Co., Ltd.; Anhui Jia He Pharma Co., Ltd. romanized | CDE ↗ |
| Ethyl Iosapentate Capsules | CYHS2601563 | Generic | 2026/07/02 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2504191 | Generic | 2025/12/05 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2504190 | Generic | 2025/12/05 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Valacyclovir Hydrochloride Tablets | CYHS2502932 | Generic | 2025/08/12 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| 瑞巴派特片 · No verified English name | CYHS2501934 | Generic | 2025/05/30 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Colchicine Tablets | CYHS2500508 | Generic | 2025/01/27 | Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
7 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Betamethasone Sodium Phosphate Injection | Zhejiang Zhebei Pharmaceutical Co., Ltd. | ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. | 国药准字H20263158 | 2026/01/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcitriol Soft Capsules | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H20255130 | 2025/08/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mercaptopurine Tablets | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H33020001 | 2021/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ribavirin Tablets | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H10940109 | 2021/05/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ribavirin Tablets | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H10940014 | 2021/05/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acyclovir Tablets | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H33020005 | 2020/11/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acyclovir Tablets | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Zhejiang Zhebei Pharmaceutical Co., Ltd. | 国药准字H33020004 | 2020/11/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
7 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 巯嘌呤 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20250001464 | I | 2026/01/05 | CDE ↗ |
| 甲氨蝶呤 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20240000793 | A | 2026/04/29 | CDE ↗ |
| 阿昔洛韦 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20190008308 | A | 2023/12/02 | CDE ↗ |
| 利巴韦林 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20190007498 | A | 2024/02/05 | CDE ↗ |
| 氨酪酸 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20190007495 | A | 2024/02/05 | CDE ↗ |
| 盐酸西替利嗪 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20190007487 | A | 2024/02/05 | CDE ↗ |
| 甲磺酸左氧氟沙星 · No verified English name | Zhejiang Zhebei Pharmaceutical Co., Ltd. | Y20190004320 | A | 2024/12/11 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
18 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Fosfomycin Sodium For Injection | CYHS2602780 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Fosfomycin Sodium For Injection | CYHS2602779 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Fosfomycin Sodium For Injection | CYHS2602778 | Generic | 2026/11/11 | Zhejiang AngLiKang Pharmaceutical CO.,LTD.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Liniment | CYHB2601726 | Supplement | 2026/09/11 | Hunan Kerey Pharmaceutical Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Liniment | CYHB2601725 | Supplement | 2026/09/11 | Hunan Kerey Pharmaceutical Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| 双氯芬酸钠搽剂 · No verified English name | CYHS2600704 | Generic | 2026/03/24 | Jing Shi (Hangzhou) Pharma Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Colchicine Tablets | CYHS2600303 | Generic | 2026/01/29 | Shanghai Li Xiang Pharmaceutical Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Bifonazole Solution | CYHS2502740 | Generic | 2025/07/30 | Anhui Tai Du Biopharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Pregabalin Oral Solution | CYHS2502452 | Generic | 2025/07/09 | Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHB2501180 | Supplement | 2025/06/12 | Zhong Shan Ke Ke Kang Pharmaceutical Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Bifonazole Solution | CYHS2501987 | Generic | 2025/06/05 | Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Colchicine Tablets | CYHS2501148 | Generic | 2025/03/22 | Yi Jia Pharma (Hubei) Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| 硫唑嘌呤片 · No verified English name | CYHB2402069 | Supplement | 2024/12/06 | Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷酸腺嘌呤片 · No verified English name | CYHB2301702 | Supplement | 2023/07/29 | Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Methotrexate Tablets | CYHS2300574 | Generic | 2023/02/18 | Jiangsu Bai Ao Xin Kang Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2201734 | Generic | 2022/10/14 | Hangzhou Shang He Health Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Ribavirin Tablets | CYHB2201155 | Supplement | 2022/07/14 | Bai Shan Technology (Hu Zhou) Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
| Acyclovir Tablets | CYHB2200783 | Supplement | 2022/05/12 | Zhejiang Zhi Xin Pharmaceuticals Technology Co., Ltd. romanized; Zhejiang Zhebei Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.